1.Effect of postoperative local injection of platelet-rich plasma in ankle fractures associated with lower tibiofibular injuries on the patients'early inflammatory response and functional recovery
Jiong HUA ; Jun GONG ; Min ZHENG ; Guibao ZHANG ; Honliang WU
Journal of Clinical Surgery 2024;32(11):1205-1209
		                        		
		                        			
		                        			Objective To observe the effect of postoperative local injection of platelet-rich plasma(PRP)on patients'early inflammatory response and functional recovery in ankle fractures with lower tibiofibular injuries.Methods Fifty ankle fracture patients with lower tibiofibular injuries admitted to our hospital from January 2017 to December 2022 with postoperative local injection of PRP were selected as the PRP group,and 50 ankle fracture patients with lower tibiofibular injuries undergoing surgical treatment with ligament repair protocols in the same time period with their matched gender and age were selected as the conventional group.We compared the postoperative conditions,postoperative 3 d swelling,postoperative pain visual analogue(VAS)scores and levels of platelet-derived growth factor(PDGF),transforming growth factor β1(TGF-β1),and inflammatory mediators in the two groups,and counted the 24-week postoperative good rate,ankle plantarflexion-dorsiflexion mobility,the quality of the restoration,and the complications in the two groups.Results The swelling grading in the PRP group was lower than that in the conventional group(28 cases of grade Ⅰ,20 cases of grade Ⅱ,and 2 cases of gradeⅢ)in the 3 d postoperative period(15 cases of grade Ⅰ,23 cases of grade Ⅱ,and 12 cases of gradeⅢ),and the VAS scores in the 3 d and 7 d postoperative period[(3.24±0.61)and(2.40±0.42)points]were lower than those in the conventional group[(3.78±0.74)and(2.96±0.55)],and the lower limb weight-bearing activity time(4.01±0.65)weeks,fracture healing time(3.05±0.42)months,and postoperative return to normal work time(3.17±0.47)months were shorter than those in the conventional group[weight-bearing activity time of lower limbs(4.29±0.74)weeks,fracture healing time(3.23±0.48)months,and postoperative return to normal work time(3.40±0.59)months].While the operation time(106.53±19.77)min,number of intraoperative fluoroscopies(14.47±3.23)times,and intraoperative blood loss(84.07±25.60)ml were not statistically different from those of the conventional group[operation time(108.20±18.41)min,number of intraoperative fluoroscopies(14.53±3.06)times,and intraoperative blood loss(86.23±22.17)ml]were not statistically different when compared(P>0.05).There was no statistical difference in the comparison of preoperative inflammatory mediators,PDGF,and TGF-β1 between the two groups(P>0.05).In both groups,PDGF was higher and interleukin-6(IL-6),TGF-β1,C-reactive protein(CRP),and tumour necrosis factor-α(TNF-α)were lower at 12 weeks postoperatively compared with the preoperative period(P<0.05).In the PRP group,the postoperative PDGF was higher than that of the conventional group,and the inflammatory mediators and TGF-β1 were lower than those of the conventional group at 12 weeks postoperatively(P<0.05).In the PRP group,the postoperative 24 week good rate and ankle plantarflexion-dorsiflexion mobility were higher than that of the conventional group,and the inferior tibiofibular coalition anterior spacing(ITFACS)and inferior tibiofibular coalition posterior spacing(ITFPCS)were lower than that of the conventional group,and there was no statistically significant difference in the rate of complications when comparing the rate with that of the conventional group(P>0.05).Conclusion Local PRP injection combined with ligament repair protocol for treatment of ankle fractures with lower tibial fibula injuries accelerates patients'early functional recovery and improves the quality of anatomical repositioning,which may be related to the inhibition of inflammatory mediator release and the promotion of bone repair.
		                        		
		                        		
		                        		
		                        	
2.Evaluation of the effectiveness of transcatheter closure of fenestrated atrial septal defect via femoral vein under ultrasound guidance
SUN Bao ; CHENG Duan ; LI Bo ; HE Guibao ; WANG Haifeng ; Ahati ; Elias ; SHENG Xi ; LI Jinpeng ; Saddam Hussein ; YU Guojun ; ZHAN Shusheng ; ZHANG Ling
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2019;26(9):889-894
		                        		
		                        			
		                        			Objective     To introduce the application of transcatheter closure of multi-fenestrated atrial septal defect (ASD) via femoral vein under ultrasound guidance with amplatzer cribriform occluder (ACO) and atrial septal defect occluder (ASDO), as well as to assess its feasibility, effectiveness and safety. Methods     The clinical data of 48 patients with fenestrated ASD occluded via femoral vein under ultrasound guidance from December 2015 to May 2018 in our hospital were retrospectively analyzed, including 17 males and 31 females, aged 10 months to 51 years, an average of 11.50±13.86 years, and weighting 6-79 (27.00±20.14) kg. Among 48 patients with fenestrated ASD, 12 patients had double-foramen and 13 atrial septal aneurysm combined with defects and 23 multi-foramen. All patients underwent transthoracic echocardiography (TTE) or transesophageal echocardiography (TEE) to complete the closure of fenestrated ASD. Ultrasound, electrocardiogram and chest X-ray were reviewed the next day after surgery to evaluate the curative effect. Results     Forty-eight patients with ASD were treated with 49 occluders, due to one patient with two occluders. There were 29 ASDO (8-26 mm) and 20 ACO (18-34 mm). During the operation, TTE/TEE examination showed that 48 patients were completely occluded, 13 patients showed fine bundle shunt in the unreleased push notification rod, and 9 patients had fine bundle shunt after the release of push notification rod. Fine bundle shunt was found in 8 patients 24 hours after operation, and microshunt was found in 3 patients 1 year after operation. All the patients were followed up. The occluder position was good. The right heart was reduced in different degrees, and the X-ray showed that the pulmonary blood was reduced in different degrees. No arrhythmia was found by electrocardiogram after operation. Conclusion     It is a safe and effective method to use ACO and ASDO to occlude ASD through femoral approach under ultrasound guidance.
		                        		
		                        		
		                        		
		                        	
3.Sorafenib for the treatment of unresectable hepatocellular carcinoma
Wei ZHANG ; Zhiyong HUANG ; Ping HOU ; Guibao JI ; Xiaoping CHEN
Chinese Journal of General Surgery 2013;28(7):519-522
		                        		
		                        			
		                        			Objective To observe the efficacy and safety of sorafenib in the treatment of the unresectable hepatocellular carcinoma.Methods According to the inclusion criteria,33 patients with the unresectable hepatocellular carcinoma were given sorafenib (400 mg for twice per day).During the course of treatment,dose was adjusted based on the degree of the adverse effects.Tumor response to sorafenib and safety was assessed every 6-8 weeks using the modified RECIST criteria.The survial curve for the time to progression (TTP) and overall survival (OS) were estimated.Results In this series,there was no patients achieved complete response (CR) and partial response (PR),1 1 patients were evaluated as with stable disease(SD),22 patients were with progressive disease (PD).The median TTP was 5.6 months (2.3-8.9 months).The median TTP was longer in patients with BCLC B than BCLC C stage.TTP was longer in good than in poor performance status patients,and shorter in extrahepatic metastasis than in no extrahepatic metastasis patients.The overall incidence of adverse events was 75.8%.The most common adverse events were hand foot skin reaction,diarrhea,hypertension and rash.Three patients had grade 3 adverse events.Conclusions Sorafenib can extend the median time to progression in patients with unresectable hepatocellular carcinoma.Patients with earlier stage of HCC and better performance status are hopeful for more positive response to the treatment of sorafenib.
		                        		
		                        		
		                        		
		                        	
4.Experimental study of the anti-inflammatory and analgesic effects of diethyl 1,3-dicyclohexyl- 1,2,3,6-tetrahydropyrimidine-4,5-dicarboxylate.
Qun ZHANG ; Guibao ZHOU ; Linsheng LEI ; Chuanlin YU ; Nana CHEN
Journal of Southern Medical University 2012;32(4):553-556
OBJECTIVETo study the anti-inflammatory and analgesic activities of diethyl 1,3-dicyclohexyl-1,2,3,6-tetrahydropyrimidine-4,5-dicarboxylate (ZL-5010) in vivo and in vitro.
METHODSThe analgesic effect of ZL-5010 was evaluated by acetic acid-induced writhing response in mice, and the anti-inflammatory effects was assessed in mice with xylene-induced ear edema and in rats with carrageenan-induced paw edema. Mouse peritoneal exudate cells activated by bacterial lipopolysaccharides (LPS) were used to evaluate the anti-inflammatory effect of ZL-5010 in vitro. The levels of interleukin-1β (IL -1β) and tumor necrosis factor-α (TNF-α) in the cell culture supernatant were measured using enzyme-linked immunosorbent assay (ELISA).
RESULTSAt the doses of 0.25 and 0.5 mmol/kg, ZL-5010 administered by gavage once daily for 3 days significantly reduced acetic acid-induced writhing frequency and suppressed xylene-induced ear edema in mice, and alleviated paw edema induced by carrageenan in rats (P<0.05). The agent also inhibited the production of the pro-inflammatory cytokines IL-1β and TNF-α by LPS-induced mouse peritoneal exudate cells in vitro, with the statistically significant minimum effective concentrations of 10 and 20 µmol/L, respectively (P<0.05).
CONCLUSIONZL-5010 administered by gavage has anti-inflammatory and analgesic effects in mice and rats, and in mouse peritoneal exudate cell cultures, the agent also inhibits the production of the pro-inflammatory cytokines IL-1β and TNF-α.
Amino Acids, Diamino ; pharmacology ; therapeutic use ; Analgesics ; pharmacology ; therapeutic use ; Animals ; Anti-Inflammatory Agents ; pharmacology ; therapeutic use ; Cyclohexanes ; pharmacology ; therapeutic use ; Female ; Interleukin-1beta ; metabolism ; Male ; Mice ; Mice, Inbred Strains ; Pyrimidines ; pharmacology ; therapeutic use ; Rats ; Rats, Sprague-Dawley ; Tumor Necrosis Factor-alpha ; metabolism
5.Molluscicidal effect of 50% wettable powder of niclosamide ethanolamine salt combined with urea
Qingdong ZHANG ; Rongfeng WU ; Min XIAO ; Chunlan LI ; Guibao CAO ; Jinming LIN ; Chun ZHOU
Chinese Journal of Schistosomiasis Control 2010;22(1):95,99-
		                        		
		                        			
		                        			In order to evaluate the moUuseicidal effect of 50% wettable power of niclosamide ethanolamine salt(WPN)combined with urea against Oncomelania snails in the field,4 g/m~2 WPN,4 g/m~2 WPN+20 g/m2 urea and 4 g/m~2 WPN+30 g/m~2 urea were used for mollusciciding with the spraying method.The results showed after 7 days,the mortality rates of snail were 74.43% for 4 g/m~2 WPN,90.32% for 4 g/m~2 WPN+20 g/m~2 urea and 94.83% for 4 g/m~2 WPN+30 g/m~2 urea,respectively.It is indicated that WPN combined with urea can improve the molluscieidal effect significantly.
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail